A detailed history of Thompson Siegel & Walmsley LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 57,996 shares of MDXG stock, worth $486,586. This represents 0.01% of its overall portfolio holdings.

Number of Shares
57,996
Previous 57,996 -0.0%
Holding current value
$486,586
Previous $402,000 14.68%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$7.61 - $8.63 $50,226 - $56,958
6,600 Added 12.84%
57,996 $447,000
Q4 2023

Feb 07, 2024

SELL
$5.7 - $9.14 $76,260 - $122,284
-13,379 Reduced 20.65%
51,396 $451,000
Q3 2023

Nov 08, 2023

BUY
$6.35 - $8.16 $33,204 - $42,668
5,229 Added 8.78%
64,775 $472,000
Q2 2023

Aug 10, 2023

BUY
$3.14 - $6.61 $186,974 - $393,599
59,546 New
59,546 $394,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $953M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Thompson Siegel & Walmsley LLC Portfolio

Follow Thompson Siegel & Walmsley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.